Patent ID: 11919953
Assignee: AMGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 14:
15. The composition of claim 14, wherein the composition comprises (A) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 29 and a LC amino acid sequence of SEQ ID NO: 30 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 199 and a LC amino acid sequence of SEQ ID NO: 200, (B) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 29 and a LC amino acid sequence of SEQ ID NO: 30 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 219 and a LC amino acid sequence of SEQ ID NO: 2202, (C) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 59 and a LC amino acid sequence of SEQ ID NO: 60 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 199 and a LC amino acid sequence of SEQ ID NO: 2002, (D) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 59 and a LC amino acid sequence of SEQ ID NO: 60 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 219 and a LC amino acid sequence of SEQ ID NO: 220, (E) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 79 and a LC amino acid sequence of SEQ ID NO: 80 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 199 and a LC amino acid sequence of SEQ ID NO: 2002, (F) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 79 and a LC amino acid sequence of SEQ ID NO: 80 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 219 and a LC amino acid sequence of SEQ ID NO: 2202, (G) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 19 and a LC amino acid sequence of SEQ ID NO: 20 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 199 and a LC amino acid sequence of SEQ ID NO: 200, (H) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 39 and a LC amino acid sequence of SEQ ID NO: 40 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 199 and a LC amino acid sequence of SEQ ID NO: 200, (I) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 19 and a LC amino acid sequence of SEQ ID NO: 20 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 219 and a LC amino acid sequence of SEQ ID NO: 220, (K) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 39 and a LC amino acid sequence of SEQ ID NO: 40 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 219 and a LC amino acid sequence of SEQ ID NO: 220, (L) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 39 and a LC amino acid sequence of SEQ ID NO: 40 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 169 and a LC amino acid sequence of SEQ ID NO: 170, (M) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 29 and a LC amino acid sequence of SEQ ID NO: 30 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 169 and a LC amino acid sequence of SEQ ID NO: 170, or (N) a CD112R antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 99 and a LC amino acid sequence of SEQ ID NO: 100 and a TIGIT antigen binding protein comprising a HC amino acid sequence of SEQ ID NO: 169 and a LC amino acid sequence of SEQ ID NO: 170.